高值创新药品过渡基金保障模式研究——基于英国癌症药物基金的实证分析

Research on the interim fund for high-value innovative drugs:based on the empirical study of cancer drugs fund in england

为平衡患者日益增长的用药需求与医保基金可持续之间的矛盾,部分国家开始探索高值创新药品过渡基金保障模式。本文通过英国癌症药物基金的实证研究,对其“分类筛选-补偿孵化-逾期分流”的关键机制进行了系统探讨,并深入思考了过渡基金与医保基金间的作用关系,以期为完善我国高值创新药品医疗保障体系提供借鉴。

In order to balance the contradiction between patients'increasing demands for medication and the sustainable development of the medical insurance fund,several countries begin to explore the interim funds for high-value innovative drugs,which provide interim reimbursement for patients.Based on the empirical research,this article systematically discusses the key mechanism of Cancer Drugs Fund,and considers the relationship of interim fund and medical insurance fund in depth,so that provides a reference for the perfection of healthcare security system of high-value innovative drugs.